Gary Bridger

12.5k total citations · 5 hit papers
118 papers, 10.0k citations indexed

About

Gary Bridger is a scholar working on Immunology, Oncology and Hematology. According to data from OpenAlex, Gary Bridger has authored 118 papers receiving a total of 10.0k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Immunology, 49 papers in Oncology and 38 papers in Hematology. Recurrent topics in Gary Bridger's work include Chemokine receptors and signaling (45 papers), HIV Research and Treatment (33 papers) and Hematopoietic Stem Cell Transplantation (31 papers). Gary Bridger is often cited by papers focused on Chemokine receptors and signaling (45 papers), HIV Research and Treatment (33 papers) and Hematopoietic Stem Cell Transplantation (31 papers). Gary Bridger collaborates with scholars based in United States, Belgium and United Kingdom. Gary Bridger's co-authors include Renato T. Skerlj, Dominique Schols, Geoffrey Henson, Gary Calandra, Erik De Clercq, John F. DiPersio, Sigrid Hatse, Thue W. Schwartz, Simon P. Fricker and Richard T. Maziarz and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and The Journal of Experimental Medicine.

In The Last Decade

Gary Bridger

118 papers receiving 9.7k citations

Hit Papers

Rapid mobilization of mur... 2003 2026 2010 2018 2005 2009 2003 2003 2009 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonist
    2005 848 citations Hal E. Broxmeyer, Christie M. Orschell et al. The Journal of Experimental Medicine profile →
  2. Plerixafor and G-CSF versus placebo and G-CSF to mobilize hematopoietic stem cells for autologous stem cell transplantation in patients with multiple myeloma
    2009 579 citations John F. DiPersio, Auayporn Nademanee et al. Blood profile →
  3. Chemokines Acting via CXCR2 and CXCR4 Control the Release of Neutrophils from the Bone Marrow and Their Return following Senescence
    2003 576 citations Coralie Martin, Gary Bridger et al. Immunity profile →
  4. Mobilization of hematopoietic progenitor cells in healthy volunteers by AMD3100, a CXCR4 antagonist
    2003 561 citations W. Conrad Liles, Hal E. Broxmeyer et al. Blood profile →
  5. Phase III Prospective Randomized Double-Blind Placebo-Controlled Trial of Plerixafor Plus Granulocyte Colony-Stimulating Factor Compared With Placebo Plus Granulocyte Colony-Stimulating Factor for Autologous Stem-Cell Mobilization and Transplantation for Patients With Non-Hodgkin's Lymphoma
    2009 512 citations John F. DiPersio, Ivana N. Micallef et al. Journal of Clinical Oncology profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Gary Bridger 4.6k 4.3k 3.5k 2.6k 1.2k 118 10.0k
Hirokazu Tamamura 2.4k 0.5× 2.4k 0.5× 415 0.1× 3.0k 1.2× 1.0k 0.9× 217 6.7k
Geoffrey Henson 1.7k 0.4× 2.0k 0.5× 645 0.2× 944 0.4× 1.5k 1.2× 31 4.1k
Silvano Ferrini 3.0k 0.6× 5.5k 1.3× 384 0.1× 2.3k 0.9× 420 0.3× 228 8.7k
Patrick Hwu 9.4k 2.1× 10.0k 2.3× 345 0.1× 4.4k 1.7× 237 0.2× 220 15.8k
Salvatore Venuta 1.6k 0.3× 1.4k 0.3× 656 0.2× 2.2k 0.9× 384 0.3× 137 5.1k
Alan M. Gewirtz 1.2k 0.3× 1.2k 0.3× 2.3k 0.7× 4.6k 1.8× 119 0.1× 158 7.8k
George W. Muller 2.9k 0.6× 1.5k 0.3× 5.1k 1.5× 4.9k 1.9× 56 0.0× 83 8.8k
Leonard G. Presta 4.0k 0.9× 4.0k 0.9× 519 0.1× 8.1k 3.2× 205 0.2× 76 14.3k
Ronald P. Taylor 912 0.2× 4.4k 1.0× 1.6k 0.4× 1.4k 0.5× 135 0.1× 220 7.7k
Raymond J. Paxton 2.3k 0.5× 3.2k 0.8× 555 0.2× 2.8k 1.1× 119 0.1× 50 8.4k

Countries citing papers authored by Gary Bridger

Since Specialization
Citations

This map shows the geographic impact of Gary Bridger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary Bridger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary Bridger more than expected).

Fields of papers citing papers by Gary Bridger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gary Bridger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary Bridger. The network helps show where Gary Bridger may publish in the future.

Co-authorship network of co-authors of Gary Bridger

This figure shows the co-authorship network connecting the top 25 collaborators of Gary Bridger. A scholar is included among the top collaborators of Gary Bridger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gary Bridger. Gary Bridger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Skerlj, Renato T., Gary Bridger, Ernest J. McEachern, et al.. (2010). Synthesis and SAR of novel CXCR4 antagonists that are potent inhibitors of T tropic (X4) HIV-1 replication. Bioorganic & Medicinal Chemistry Letters. 21(1). 262–266. 30 indexed citations
2.
DiPersio, John F., Ivana N. Micallef, Patrick J. Stiff, et al.. (2009). Phase III Prospective Randomized Double-Blind Placebo-Controlled Trial of Plerixafor Plus Granulocyte Colony-Stimulating Factor Compared With Placebo Plus Granulocyte Colony-Stimulating Factor for Autologous Stem-Cell Mobilization and Transplantation for Patients With Non-Hodgkin's Lymphoma. Journal of Clinical Oncology. 27(28). 4767–4773. 512 indexed citations breakdown →
3.
4.
Devine, Steven M., Ravi Vij, Michael P. Rettig, et al.. (2008). Rapid mobilization of functional donor hematopoietic cells without G-CSF using AMD3100, an antagonist of the CXCR4/SDF-1 interaction. Blood. 112(4). 990–998. 234 indexed citations
5.
Larochelle, André, Allen E. Krouse, Mark E. Metzger, et al.. (2006). AMD3100 mobilizes hematopoietic stem cells with long-term repopulating capacity in nonhuman primates. Blood. 107(9). 3772–3778. 142 indexed citations
6.
Chen, Jing, André Larochelle, Simon P. Fricker, et al.. (2006). Mobilization as a preparative regimen for hematopoietic stem cell transplantation. Blood. 107(9). 3764–3771. 59 indexed citations
7.
Früehauf, Stefan, Patrick Maier, Li Li, et al.. (2006). The CXCR4 antagonist AMD3100 releases a subset of G-CSF-primed peripheral blood progenitor cells with specific gene expression characteristics. Experimental Hematology. 34(8). 1052–1059. 49 indexed citations
8.
Schols, Dominique, Kurt Vermeire, Signe Fransen, et al.. (2005). Multi-drug resistant HIV-1 is sensitive to inhibition by chemokine receptor antagonists. 250. 3 indexed citations
9.
Broxmeyer, Hal E., Christie M. Orschell, D. Wade Clapp, et al.. (2005). Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonist. The Journal of Experimental Medicine. 201(8). 1307–1318. 848 indexed citations breakdown →
10.
Vermeire, Kurt, Sigrid Hatse, Katrien Princen, et al.. (2004). Virus resistance to the CXCR4 inhibitor AMD070 develops slowly and does not induce a co-receptor switch. Antiviral Research. 62. 2 indexed citations
11.
Schols, Dominique, Kurt Vermeire, Sigrid Hatse, et al.. (2004). In vitro anti-HIV activity profile of AMD887, a novel CCR5 antagonist, in combination with the CXCR4 inhibitor AMD070. 5 indexed citations
12.
Rosenkilde, Mette M., Lars‐Ole Gerlach, Janus S. Jakobsen, et al.. (2004). Molecular Mechanism of AMD3100 Antagonism in the CXCR4 Receptor. Journal of Biological Chemistry. 279(4). 3033–3041. 195 indexed citations
13.
Mayers, Irvin, Thomas S. Hurst, Anna Radomski, et al.. (2003). Increased matrix metalloproteinase activity after canine cardiopulmonary bypass is suppressed by a nitric oxide scavenger. Journal of Thoracic and Cardiovascular Surgery. 125(3). 661–668. 19 indexed citations
14.
Schols, Dominique, Sandra Claes, Sigrid Hatse, et al.. (2003). Anti-HIV activity profile of AMD070, an orally bioavailable CXCR4 antagonist. Antiviral Research. 57(3). 4 indexed citations
15.
Princen, Katrien, Sigrid Hatse, Kurt Vermeire, et al.. (2003). The Antiviral Activity of the CXCR4 Antagonist AMD3100 Is Independent of the Cytokine-Induced CXCR4/HIV Coreceptor Expression Level. AIDS Research and Human Retroviruses. 19(12). 1135–1139. 9 indexed citations
16.
Martin, Coralie, et al.. (2003). Chemokines Acting via CXCR2 and CXCR4 Control the Release of Neutrophils from the Bone Marrow and Their Return following Senescence. Immunity. 19(4). 583–593. 576 indexed citations breakdown →
17.
Lukacs, Nicholas W., Aaron A. Berlin, Dominique Schols, Renato T. Skerlj, & Gary Bridger. (2002). AMD3100, a CxCR4 Antagonist, Attenuates Allergic Lung Inflammation and Airway Hyperreactivity. American Journal Of Pathology. 160(4). 1353–1360. 165 indexed citations
18.
Matthys, Patrick, Sigrid Hatse, Kurt Vermeire, et al.. (2001). AMD3100, a Potent and Specific Antagonist of the Stromal Cell-Derived Factor-1 Chemokine Receptor CXCR4, Inhibits Autoimmune Joint Inflammation in IFN-γ Receptor-Deficient Mice. The Journal of Immunology. 167(8). 4686–4692. 215 indexed citations
19.
Esté, José A., Cecilia Cabrera, Erik De Clercq, et al.. (1999). Activity of Different Bicyclam Derivatives against Human Immunodeficiency Virus Depends on Their Interaction with the CXCR4 Chemokine Receptor. Molecular Pharmacology. 55(1). 67–73. 3 indexed citations
20.
Gelder, J. Van, Myriam Witvrouw, Christophe Pannecouque, et al.. (1999). Evaluation of the potential of ion pair formation to improve the oral absorption of two potent antiviral compounds, AMD3100 and PMPA. International Journal of Pharmaceutics. 186(2). 127–136. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hirokazu Tamamura Breakdown of academic impact, for papers by Geoffrey Henson Breakdown of academic impact, for papers by Silvano Ferrini Breakdown of academic impact, for papers by Patrick Hwu Breakdown of academic impact, for papers by Salvatore Venuta Breakdown of academic impact, for papers by Alan M. Gewirtz Breakdown of academic impact, for papers by George W. Muller Breakdown of academic impact, for papers by Leonard G. Presta Breakdown of academic impact, for papers by Ronald P. Taylor Breakdown of academic impact, for papers by Raymond J. Paxton
Rankless by CCL
2026